Omar Al‐Janabi

ORCID: 0000-0003-2208-4308
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dementia and Cognitive Impairment Research
  • Acute Ischemic Stroke Management
  • Advanced Neuroimaging Techniques and Applications
  • Cerebrovascular and Carotid Artery Diseases
  • Protease and Inhibitor Mechanisms
  • Alzheimer's disease research and treatments
  • Venous Thromboembolism Diagnosis and Management
  • Prostate Cancer Treatment and Research
  • Stroke Rehabilitation and Recovery
  • Neurological Disease Mechanisms and Treatments
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Cancer Genomics and Diagnostics
  • Renal and related cancers
  • Functional Brain Connectivity Studies
  • S100 Proteins and Annexins
  • Cardiac Structural Anomalies and Repair
  • Chromosomal and Genetic Variations
  • Cell Adhesion Molecules Research
  • Ginger and Zingiberaceae research
  • Peptidase Inhibition and Analysis
  • Mast cells and histamine
  • Infectious Encephalopathies and Encephalitis
  • Atrial Fibrillation Management and Outcomes
  • Health and Well-being Studies
  • Vascular Malformations Diagnosis and Treatment

Central Baptist Hospital
2024-2025

Banner - University Medical Center Tucson
2024

University of Arizona
2024

University of Kentucky
2016-2023

Universitätsklinikum Erlangen
2013-2019

Friedrich-Alexander-Universität Erlangen-Nürnberg
2012-2019

Methodist Hospital
2016

University of Washington
2016

University of Pennsylvania
2016

This study aimed to assess the applicability of miR-375 in combination with soluble urokinase plasminogen activator receptor (suPAR) protein as a diagnostic and/or prognostic biomarker for prostate cancer (PCa) patients. levels by qRT-PCR and suPAR ELISA were evaluated serum samples from 146 PCa patients, 35 benign hyperplasia (BPH) patients 18 healthy controls. Antigen differed between controls or BPH whereas (p < 0.001). Additionally, Gleason sum groups GS = 7 versus > 7, higher latter...

10.1002/ijc.29505 article EN International Journal of Cancer 2015-03-06

Background Left ventricular assist devices (LVADs) are used as definitive therapy or a bridge to heart transplant in patients with advanced failure. Thromboembolic complications such acute ischemic stroke (AIS) common among LVAD support. This study aims evaluate the current evidence on efficacy and safety of mechanical thrombectomy (MT) AIS due large vessel occlusions (LVO) LVAD-support. Methods A comprehensive systematic review was conducted PubMed, Embase, Scopus find observational studies...

10.1136/jnis-2024-022792 article EN Journal of NeuroInterventional Surgery 2025-01-23

Small cerebral vascular disease (SCeVD) demonstrated by white matter hyperintensity (WMH) on MRI contributes to the development of dementia in Alzheimer's (AD), but it has not been possible correlate onset, severity, or protein components SCeVD with characteristics WMH living patients.Plasma endothelial-derived exosomes (EDEs) were enriched two-step immunoabsorption from four groups participants no clinical evidence cerebrovascular disease: cognitively normal (CN) without (CN SCeVD, n = 20),...

10.1096/fj.202000034r article EN The FASEB Journal 2020-03-10

Subcortical white matter hyperintensities (WMHs) in the aging population frequently represent vascular injury that may lead to cognitive impairment. WMH progression is well described, but factors underlying regression remain poorly understood. A sample of 351 participants from Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2) was explored who had volumetric quantification, structural brain measures, and measures (memory executive function) at baseline after approximately years. Selected...

10.3390/brainsci9070170 article EN cc-by Brain Sciences 2019-07-19

Background: Alzheimer’s disease (AD) pathology and hypertension (HTN) are risk factors for development of white matter (WM) alterations might be independently associated with these in older adults. Objective: To evaluate the independent synergistic effects HTN AD on WM alterations. Methods: Clinical measures cerebrovascular were collected from 62 participants University Kentucky Disease Center studies who also had cerebrospinal fluid (CSF) sampling MRI brain scans. CSF Aβ 1-42 levels...

10.3233/jad-180663 article EN Journal of Alzheimer s Disease 2018-10-29

MIR143 is pathologically downregulated and may function as a tumor suppressor in prostate cancer. Likewise, the urokinase plasminogen activator receptor (UPAR) overexpressed carcinoma, representing negative prognostic marker putative therapeutic target gene. In this paper, we establish UPAR new direct of MIR143. Luciferase reporter gene constructs identify one two silico-predicted binding sites functionally relevant for to 3' UTR, and, concomitantly, transfection reduces protein levels...

10.1016/j.omtn.2019.02.020 article EN cc-by-nc-nd Molecular Therapy — Nucleic Acids 2019-02-27

The objective was to determine the mRNA expression and protein levels of uPA system components in tissue specimens serum samples, respectively, from prostate cancer (PCa) patients assess their association with clinicopathological parameters overall survival (OS). uPA, its receptor (uPAR), inhibitor type 1 (PAI-1) were analyzed corresponding malignant adjacent nonmalignant 132 PCa by quantitative PCR. Preoperative samples 81 for antigen members ELISA. RNA displayed significant correlations...

10.1155/2014/972587 article EN cc-by BioMed Research International 2014-01-01

ABSTRACT BACKGROUND AND PURPOSE Interpreting the clinical significance of moderate‐to‐severe global cerebral atrophy (GCA) is a conundrum for many clinicians, who visually interpret brain imaging studies in routine practice. GCA may be attributed to normal aging, Alzheimer's disease (AD), or cerebrovascular (CVD). Understanding relationships with AD, and CVD important accurate diagnosis treatment decisions cognitive complaints. METHODS To elucidate relative associations age, white matter...

10.1111/jon.12494 article EN Journal of Neuroimaging 2018-01-05

Previous research has indicated that miR-107 may play important roles in both metabolism and AD pathogenesis be modulated by "fibrates" (PPAR-alpha agonists). Fibrates increase expression, leading to down-regulation of BACE1 protein. We evaluated the safety efficacy gemfibrozil administration predementia Alzheimer's disease a parallel-design, double-blind, placebo-controlled clinical trial funded NIH/NIA R01 AG042419 registered on clinicaltrials.gov NCT02045056. Patients with pAD, MCI, or...

10.1016/j.jalz.2019.06.4682 article EN Alzheimer s & Dementia 2019-07-01

Abstract Background When and how to communicate effectively the results of genetic biomarker based prediction, detection, quantification brain substrates dementia involve important ethical legal issues critical for precision medicine. The urgency issue has increased as People Living with Dementia (PLwD) Risk (PwRD) can access direct consumer testing, amyloid targeting drugs, clinical PET scans. To address need effective dissemination consultation, an advisory group was convened that welcomes...

10.1002/alz.045562 article EN Alzheimer s & Dementia 2020-12-01

To shed light on the COVID-19 related encephalitis and its associated CSF imaging findings

10.1212/wnl.96.15_supplement.1436 article EN Neurology 2021-04-13

Abstract Background: Members of the urokinase-type plasminogen activator (uPA) system play an important role in tumor progression and angiogenesis different human malignancies including breast, kidney, colon, stomach prostate cancer (PCa). The objective this study was to determine mRNA expression protein levels uPA components tissue specimens serum samples, respectively, from patients with PCa, assess their potential association clinic-pathological parameters overall survival (OS). Material...

10.1158/1538-7445.am2014-39 article EN Cancer Research 2014-10-01
Coming Soon ...